Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

78.94
-1.0100-1.26%
Volume:169.51K
Turnover:13.35M
Market Cap:3.46B
PE:-72.93
High:80.01
Open:80.01
Low:77.89
Close:79.95
52wk High:91.53
52wk Low:48.76
Shares:43.88M
Float Shares:35.64M
Volume Ratio:0.50
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.99
PE(LYR):-49.65

Loading ...

Q32 Bio Names José Trevejo Chief Medical Officer

Reuters
·
Sep 14

Tarsus Pharmaceuticals Completes Alkeus Retinal Therapy Acquisition

TIPRANKS
·
Sep 11

Tarsus COO Neervannan Seshadri Sells 4,564 Shares Worth $387,940

Reuters
·
Sep 10

Tarsus Pharmaceuticals is Maintained at Buy by Jefferies

Dow Jones
·
Sep 09

Tarsus Pharmaceuticals price target raised to $105 from $88 at Jefferies

TIPRANKS
·
Sep 09

Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline

TIPRANKS
·
Sep 09

Tarsus Pharmaceuticals Closes Acquisition of Alkeus Pharmaceuticals

MT Newswires Live
·
Sep 04

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

THOMSON REUTERS
·
Sep 04

Tarsus CMO Elizabeth Yeu Disposes of Common Shares Worth $787,879.86

Reuters
·
Sep 04

Tarsus Pharmaceuticals to Attend Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Tarsus to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Tarsus Pharmaceuticals (TARS) Shares Just Moved, What Is Behind The Attention?

Simply Wall St.
·
Aug 18

Tarsus Pharmaceuticals Price Target Raised to $100.00/Share from $97.00 by Oppenheimer

Dow Jones
·
Aug 12

Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating

MT Newswires Live
·
Aug 12

Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus

Simply Wall St.
·
Aug 09

Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet

TIPRANKS
·
Aug 07

Tarsus Pharmaceuticals Q2 EPS $(0.43) Misses $(0.20) Estimate, Sales $173.912M Beat $169.677M Estimate

Benzinga Earnings
·
Aug 07

Verrica Pharma Reports Wider-than-Expected Q2 Adj Loss Per Share

Reuters
·
Aug 07

Tarsus Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06